GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo.
Where this comes from
- Record sourced from PubMed, PMID 41490510.
- Also identified by DOI 10.7326/ANNALS-25-05161-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text] Gastroenterology: [Formula: see text].
Medical subject headings
- Gastroesophageal Reflux
- Cholelithiasis
- Hypoglycemic Agents